Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrome Type 3
Clinical trial NCT02300558 · TERMINATED
Trial details
- NCT number
- NCT02300558
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-17
- Primary completion
- 2016-12-12
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.